|
|
| | HYODEOXYCHOLIC ACID SODIUM SALT Basic information |
| Product Name: | HYODEOXYCHOLIC ACID SODIUM SALT | | Synonyms: | SODIUM HYODEOXYCHOLATE;3ALPHA,6ALPHA-DIHYDROXY-5BETA-CHOLAN-24-OIC ACID SODIUM SALT;5BETA-CHOLAN-24-OIC ACID-3ALPHA,6ALPHA-DIOL SODIUM SALT;3,6-dihydroxy-,monosodiumsalt,(3alpha,5beta,6alpha)-cholan-24-oicaci;hyodeoxycholic acid sodium;3α,6α-Dihydroxy-5β-cholan-24-oic acid, Hyodeoxycholic acid sodium salt;3α,6α-Dihydroxy-5β-cholan-24-oic acid sodium salt;Sodium 3α,6α-dihydroxy-5β-cholan-24-oate | | CAS: | 10421-49-5 | | MF: | C24H39NaO4 | | MW: | 414.55 | | EINECS: | 1806241-263-5 | | Product Categories: | Bile Acids;Biochemistry;Steroids | | Mol File: | 10421-49-5.mol |  |
| | HYODEOXYCHOLIC ACID SODIUM SALT Chemical Properties |
| refractive index | 3.5 ° (C=2, H2O) | | Water Solubility | Sparingly soluble in water.(0.26 g/L) (25°C), |
| | HYODEOXYCHOLIC ACID SODIUM SALT Usage And Synthesis |
| Chemical Properties | White to almost white powder | | Uses | It is used as pharmaceutical intermediate. Benzoylthiophenes are allosteric enhancers (AE) of agonist activity at the A1 adenosine receptor. | | in vivo | Hyodeoxycholic acid (HDCA; 1.25% (wt/wt)) sodium obviously decreases fat mass and increases lean mass but does not raise the serum levels of any organ toxicity markers in LDLRKO mice. Hyodeoxycholic acid inhibits atherosclerotic lesion formation in LDLRKO at multiple sites, improves plasma lipoprotein profiles, decreases plasma glucose level and intestinal cholesterol absorption efficiency and increases daily cholesterol excretion through fecal output. Hyodeoxycholic acid sodium also improves HDL function as measured by a cholesterol efflux assay[2]. | | IC 50 | Microbial Metabolite; Human Endogenous Metabolite |
| | HYODEOXYCHOLIC ACID SODIUM SALT Preparation Products And Raw materials |
|